AU1871700A - Cyclic adenosine diphosphate ribose analogues for modulating t cell activity - Google Patents

Cyclic adenosine diphosphate ribose analogues for modulating t cell activity

Info

Publication number
AU1871700A
AU1871700A AU18717/00A AU1871700A AU1871700A AU 1871700 A AU1871700 A AU 1871700A AU 18717/00 A AU18717/00 A AU 18717/00A AU 1871700 A AU1871700 A AU 1871700A AU 1871700 A AU1871700 A AU 1871700A
Authority
AU
Australia
Prior art keywords
modulating
cell activity
adenosine diphosphate
cyclic adenosine
diphosphate ribose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18717/00A
Inventor
Ingeborg Berg
Andreas H. Guse
Georg W. Mayr
Barry V. L. Potter
Hendrik Schulze-Koops
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bath
Original Assignee
University of Bath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bath filed Critical University of Bath
Publication of AU1871700A publication Critical patent/AU1871700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
AU18717/00A 1998-12-18 1999-12-17 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity Abandoned AU1871700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9828071 1998-12-18
GBGB9828071.2A GB9828071D0 (en) 1998-12-18 1998-12-18 Therapeutics
PCT/GB1999/004295 WO2000037089A1 (en) 1998-12-18 1999-12-17 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity

Publications (1)

Publication Number Publication Date
AU1871700A true AU1871700A (en) 2000-07-12

Family

ID=10844606

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18717/00A Abandoned AU1871700A (en) 1998-12-18 1999-12-17 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity

Country Status (5)

Country Link
EP (1) EP1140118A1 (en)
JP (1) JP2002532554A (en)
AU (1) AU1871700A (en)
GB (1) GB9828071D0 (en)
WO (1) WO2000037089A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4710401A (en) 1999-12-02 2001-06-18 University Of South Florida Method and composition for treatment of ischemic neuronal reperfusion injury
GB0019234D0 (en) * 2000-08-04 2000-09-27 Univ Bath Therapeutics
GB0113923D0 (en) * 2001-06-07 2001-08-01 Univ Bath Therapeutics
WO2017142368A2 (en) * 2016-02-19 2017-08-24 전북대학교 산학협력단 Composition for preventing and treating allergic or inflammatory skin disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706424D0 (en) * 1997-03-27 1997-05-14 Isis Innovation Cyclic adenosine diphosphate ribose analogues
JPH11310596A (en) * 1998-04-28 1999-11-09 Seibutsu Bunshi Kogaku Kenkyusho:Kk Myeloid interstitial cell antigen binding protein

Also Published As

Publication number Publication date
EP1140118A1 (en) 2001-10-10
JP2002532554A (en) 2002-10-02
GB9828071D0 (en) 1999-02-17
WO2000037089A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
AU3878399A (en) Hydrogen electrochemical system environment
PL346653A1 (en) Methods, instruments and materials for chondrocyte cell transplantation
IL138543A0 (en) Architecture for corob based computing system
AU3943699A (en) Exhaust system
AU9660698A (en) Dna methyltransferase genotyping
AU8584398A (en) Thermal conductor for high-energy electrochemical cells
AU4241296A (en) Purine nucleoside modifications by palladium catalyzed methods
PL345089A1 (en) Adenosine derivatives
AU1710899A (en) Cyclic gmp phosphodiesterase
AU8334298A (en) Nociceptin analogues
AU6505299A (en) Methods for generating antigen-reactive t cells (in vitro)
AU6381098A (en) Ventilation system for electrolytic cell
AU1871700A (en) Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
HUP0104827A2 (en) Antiviral nucleoside analogues
AU1080899A (en) Methods for increasing schwann cell survival
AU5321398A (en) Stabilized aqueous nucleoside triphosphate solutions
AU6843998A (en) Cyclic adenosine diphosphate ribose analogues
AU2338101A (en) Imidazopyrimidine nucleoside analogues with anti-hiv activity
AU2001275732A1 (en) Naadp analogues for modulating t-cell activity
AU6634298A (en) Biosensor for cells
AU9392298A (en) Cyclic phosphites and phosphates
AU5250399A (en) Sterol methyltransferase gene
AU5891799A (en) Simulation system i
AU3474499A (en) High-throughput method for screening for antiviral activity
AU6518296A (en) Pyrimidine nucleoside derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase